24-C-046
3. Discussion with possible action to consider the cost benefit analysis of including anti-obesity medications (AOM) approved by the United States of America (USA) Food and Drug Administration (FDA) in the City of Laredo employees’ health insurance benefits package, and any other matters incident thereto.
- Committee
- City Council
- Requested by
- Dr. David Tyler King
- Introduced
- February 14, 2024
- On agenda
- February 20, 2024
- Passed
- February 20, 2024